Effectiveness of Double-Dose Dolutegravir in People Receiving Rifampin-based Tuberculosis Treatment: An Observational, Cohort Study of People With HIV From 6 Countries is a research paper published in Clinical Infectious Diseases (2024). On theSindex it has a DataRank of 0.241. It has been cited 4 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.241
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIAID NIH HHS
Grant: UM1 AI068634
NIAID NIH HHS
Grant: UM1 AI069423
NIAID NIH HHS
Grant: UM1 AI069432
NIAID NIH HHS
Grant: UM1 AI106701
NIAID NIH HHS
Grant: UM1 AI068636
NIAID NIH HHS
Grant: UM1 AI06866
NIAID NIH HHS
Grant: UM1 AI069421
NIAID NIH HHS
Grant: UM1 AI069453
NIAID NIH HHS
Grant: P30 AI168386
NIAID NIH HHS
Grant: UM1 AI069501
NIAID NIH HHS
Grant: P30 AI050410
NIAID NIH HHS
Grant: UM1 AI069518
NIAID NIH HHS
Grant: UM1 AI069519
NIAID NIH HHS
Grant: UM1 AI108568
NIAID NIH HHS
Grant: K24 AI165099
ACTG
Grant: UM1AI69518
NIAID NIH HHS
Grant: U01 AI069463
NIAID NIH HHS
Grant: UM1 AI069463
NIAID NIH HHS
Grant: UM1 AI069494
NIAID NIH HHS
Grant: U01 AI068636
NIAID NIH HHS
Grant: UM1 AI069436
National Institute of Allergy and Infectious Diseases
National Institute of Allergy and Infectious Diseases
FWCI
1.50
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals